Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. junior Avg
|
|
New words:
annum, ASIC, attempt, Australian, Bidder, bifurcation, bitcoin, blockchain, borrowing, CFO, circuit, clear, commensurate, cryptocurrency, CVR, Dannenberg, daughter, Deed, Derecognition, Eastern, economy, embody, encumber, enjoin, epidemic, equitable, freely, Hapoalim, hardware, HCW, hereinafter, implicit, imputed, inconsistent, infrastructure, insolvency, judgement, lodged, methodology, mining, modular, NC, NDH, NEI, NovaSight, numeric, outlook, Overview, pendency, penetration, point, pro, proportion, proven, rata, rescission, revert, securityholder, signatory, sooner, sophisticated, SPA, specialist, SpringVision, subgroup, subset, Subtopic, surrender, surrendered, Sydney, thereon, unconditional, undertaken, unsecured, unvested, uplisting, USD, VAS, verified, voluntarily, workforce, worth
Removed:
acquirer, aforesaid, applicability, BCF, Bnei, bore, Brak, Brian, Brooser, Bulletin, Catholic, charge, Chibret, committed, complied, consumer, correspondingly, Debenture, declaring, delivered, DGCL, direction, discourage, edited, Eliahu, Eliyahu, emerging, entitling, exact, execute, exercised, Ferenc, floating, fractional, Franck, freeze, frequency, golden, Guaranty, Halfon, HaRav, hawse, hereto, imposition, incurrence, irrevocable, Jonathan, Jumpstart, lien, Mayron, motion, nearest, Nemeth, Nil, nonconvertible, occurring, Ocu, ophthalmologic, Oxley, Papolczy, parachute, Pazmany, Peretz, Peter, Philippe, postpone, prefer, Prize, receiver, recommended, registering, removed, repay, restricting, retired, Ron, rotation, Rozovski, ruling, Sadan, scaled, Schulek, Shmuel, Simcha, surgeon, Szeged, tail, tandem, title, triangular, unaudited, Wall, Yaakov, Yosef, Zarachia
Filing tables
Filing exhibits
- 10-K Annual report
- 4.2 Description of Securities
- 10.40 Amendment to Exclusive Distribution and Licensing Agreement by and Between Wize Pharma LTD., Ocuwize LTD. and Resdevco Research and Development Company LTD., Dated May 4, 2020
- 21.1 Subsidiaries of the Company
- 23.1 Consent of Independent Registered Public Accounting Firm
- 31.1 Certification
- 31.2 Certification
- 32.1 Certification
- 32.2 Certification
- Download Excel data file
- View Excel data file
MIGI similar filings
Filing view
External links